Phospholipase A2 and acute lung injury: It's just not that simple

Critical Care Medicine

Volumn 33, Issue 4, 2005, Pages 904-905

  Wheeler, Derek S ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Acute respiratory distress syndrome; Phospholipase A2; Platelet activating factor acetylhydrolase; Surfactant; Type II secretory phospholipase A2

Indexed keywords

LEUKOTRIENE; LIPOXYGENASE; PHOSPHOLIPASE A2; PHOSPHOLIPASE A2 INHIBITOR; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE; THROMBOCYTE ACTIVATING FACTOR; THROMBOXANE; BIOLOGICAL MARKER; ENZYME INHIBITOR; PHOSPHOLIPASE A;

ACUTE LUNG INJURY; ATELECTASIS; CAPILLARY PERMEABILITY; CELL ACTIVATION; CRITICAL ILLNESS; CYTOKINE PRODUCTION; CYTOTOXICITY; EDITORIAL; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LOCALIZATION; HUMAN; LEUKOCYTE ADHERENCE; LUNG ALVEOLUS MACROPHAGE; LUNG CIRCULATION; LUNG LAVAGE; LUNG VENTILATION PERFUSION RATIO; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FAMILY; PROTEIN SYNTHESIS; ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL; CHEMISTRY; DRUG ANTAGONISM; ENZYMOLOGY; METABOLISM; NOTE; TREATMENT OUTCOME;

ANIMALS; BIOLOGICAL MARKERS; BRONCHOALVEOLAR LAVAGE FLUID; ENZYME INHIBITORS; HUMANS; PHOSPHOLIPASES A; RESPIRATORY DISTRESS SYNDROME, ADULT; TREATMENT OUTCOME;

EID: 17044397834     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000159694.64555.F8     Document Type: Editorial

References (15)

1. Touqui L, Arbibe L: A role for phospholipase A2 in ARDS pathogenesis. Mol Med Today 1999; 5:244-249
2. 2. Annu Rev Phamacol Toxicol 1999; 39:175-189
3. 2 in animal models of acute lung injury. Eur Respir J 2003; 21:1040-1045
4. 2 in oleic acid-induced acute lung injury in rabbits. Am J Respir Crit Care Med 1999; 160:1292-1302
5. 2 inhibitor in rabbit acute lung injury: Correlation with lung surfactant protection. Crit Care Med 2001; 29:719-727
6. 2 activities are increased in human adult respiratory distress syndrome. Am J Physiol 1995; 269:109-118
7. Nakos G, Kitsiouli E, Tsangas I, et al: Bronchoalveolar lavage fluid characteristics of early intermediate and late phases of ARDS: Alterations in leukocytes, proteins, PAF, and surfactant components. Intensive Care Med 1998; 24:296-303
8. 2-induced pathophysiologic changes in the guinea pig lung. Am J Pathol 1990; 136: 1283-1291
9. 2 and platelet-activating-factor acetylhydrolase in patients with acute respiratory distress syndrome. Crit Care Med 2005; 33:772-779
10. 2 protein interaction. J Clin Invest 1998; 102:1152-1160
11. 2. J Immunol 2003; 171:995-1000
12. 2 induce the expression of chemokines in microvascular endothelium. Biochem Biophys Res Comm 2003; 300:731-737
13. 2. Nat Immunol 2000; 1:42-46
14. 2, arachidonyl trifluoromethyl ketone, attenuates LPS-induced lung injury in mice. Am J Physiol Lung Cell Mol Physiol 2003; 284:L720-L726
15. 2, in patients with suspected sepsis and organ failure. Crit Care Med 2003; 31:718-728